NOBO Medicine

NOBO Medicine is a company that focuses on the development of drugs driven by novel biomarkers in the field of precision medicine in oncology and chronic inflammatory diseases. Founded in 2017, the company's mission is to identify and target patient groups with strong unmet needs through their patient-oriented translational approach. They aim to break new ground in precision medicine, particularly in the areas of chronic inflammatory diseases and oncology. Despite the lack of specific information on industries, headquarter location, and last investment, NOBO Medicine presents an intriguing opportunity in the evolving landscape of precision medicine. The company's commitment to addressing unmet needs and leveraging novel biomarkers positions it as a potential player in the rapidly growing precision medicine market.